Individualized intensive insulin therapy of diabetes: Not only thegoal, but also the time  

作　　者：Yun Hu Hong-Jing Chen Jian-Hua Ma 

机构地区：[1]Department of Endocrinology,The Affiliated Wuxi People's Hospital of Nanjing Medical University,Wuxi People's Hospital,Wuxi Medical Center,Nanjing Medical University,Wuxi 214023,Jiangsu Province,China [2]Department of Endocrinology,Nanjing First Hospital,Nanjing 210000,Jiangsu Province,China

出　　处：《World Journal of Diabetes》2024年第1期11-14,共4页世界糖尿病杂志（英文版）（电子版）

摘　　要：Intensive insulin therapy has been extensively used to control blood glucose levels because of its ability to reduce the risk of chronic complications of diabetes.According to current guidelines,intensive glycemic control requires individu-alized glucose goals rather than as low as possible.During intensive therapy,rapid blood glucose reduction can aggravate microvascular and macrovascular complications,and prolonged overuse of insulin can lead to treatment-induced neuropathy and retinopathy,hypoglycemia,obesity,lipodystrophy,and insulin antibody syndrome.Therefore,we need to develop individualized hypoglycemic plans for patients with diabetes,including the time required for blood glucose normalization and the duration of intensive insulin therapy,which deserves further study.

关 键 词：DIABETES Intensive therapy INSULIN Treatment-induced neuropathy 

分 类 号：R587.1[医药卫生—内分泌]